24.08.2013 Views

2008 Barcelona - European Society of Human Genetics

2008 Barcelona - European Society of Human Genetics

2008 Barcelona - European Society of Human Genetics

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Clinical genetics<br />

birth defects is similar to developmental anomalies that are observed in<br />

an animal model with vitamin A or retinoic acid deficiency. We describe<br />

an infant with hypoplastic left heart, right pulmonary artery and lung hypoplasia,<br />

eventration <strong>of</strong> right hemidiaphragm, complete hypospadias<br />

and absent gonads . The karyotype was normal (46,XY) and FISH for<br />

SRY locus was present . Endocrine evaluations were suggestive <strong>of</strong> primary<br />

hypogonadism . Low testosterone, AMH (anti mullerian hormone)<br />

and Inhibin B values along with absence <strong>of</strong> visualized testicular tissue<br />

and Mullerian structures by imaging studies, indicated a defect in early<br />

embryogenesis . Interestingly, the level <strong>of</strong> plasma free retinol was low,<br />

consistent with severe vitamin A deficiency, supporting the hypothesis<br />

that a defect in vitamin A metabolism may have an etiological role in<br />

this syndrome with multiple congenital anomalies .<br />

P01.343<br />

Perrault syndrome: Report <strong>of</strong> Four New cases, Review and<br />

Exclusion <strong>of</strong> candidate Genes<br />

S. Marlin 1,2 , D. Lacombe 3 , L. Jonard 4 , N. Leboulanger 4 , D. Bonneau 5 , C.<br />

Goiset 3 , T. Billette de Villemeur 4 , S. Cabrol 4 , M. Houang 4 , D. Feldmann 4 , F.<br />

Denoyelle 4 ;<br />

1 Hôpital Armand Trousseau, paris, France, 2 INSERM U587, Centre de référence<br />

des surdités génétiques, Paris, France, 3 Hôpital Pellegrin, Bordeaux,<br />

France, 4 Hôpital Armand Trousseau, Paris, France, 5 CHU, Angers, France.<br />

Sensorineural hearing impairment and ovarian dysgenesis are the<br />

main clinical signs <strong>of</strong> the Perrault syndrome. This syndrome was first<br />

described by Perrault et al in 1951. Since this first report, about 30<br />

cases were described . More recently, some authors have reported<br />

neurologic abnormalities in Perrault syndrome, in particular progressive<br />

cerebellar ataxia and mental retardation . We present here on<br />

three sporadic and two familial new cases <strong>of</strong> Perrault syndrome . Only<br />

two <strong>of</strong> them present with neurological defect . We analyse the clinical<br />

features <strong>of</strong> this five patients and review the published cases in order<br />

to evaluate the frequency <strong>of</strong> the neurological defect in this syndrome .<br />

Moreover, we exclude GBG2, POLG and FOXL2 as candidate genes<br />

in Perrault syndrome .<br />

P01.344<br />

susceptibility markers for PFAPA disease<br />

R. Gershoni-Baruch 1,2 , E. Dagan 1,3 , K. Ihab 4 , A. Mori 1 , N. Amar 1 , R. Brik 4,2 ;<br />

1 Rambam Health Care Campus, Institute <strong>of</strong> <strong>Human</strong> <strong>Genetics</strong>, Haifa, Israel,<br />

2 The Ruth and Bruce Rappaport Faculty <strong>of</strong> Medicine, Technion-Institute <strong>of</strong><br />

Technology, Haifa, Israel, 3 Department <strong>of</strong> Nursing, University <strong>of</strong> Haifa, Haifa,<br />

Israel, 4 Rambam Health Care Campus, Department <strong>of</strong> Pediatrics, Haifa, Israel.<br />

Periodic fever syndrome (PFAPA) is characterized by aphthous stomatitis,<br />

pharyngitis and cervical adenitis . The periodic fever and autoinflammatory<br />

syndromes constitute a group <strong>of</strong> diseases characterized<br />

by repeated febrile illnesses associated with various other symptoms .<br />

Except for PFAPA, the genetic basis <strong>of</strong> each <strong>of</strong> these diseases is<br />

known . Predominant mutations in MEFV, TNF1A and CARD15/NOD2<br />

were analyzed in 57 children diagnosed with PFAPA .<br />

Children with PFAPA were carefully selected based on clinical signs<br />

and symptoms . All patients were recruited at the Department <strong>of</strong> Pediatrics,<br />

Meyer Hospital <strong>of</strong> Children, Rambam-Health Care Campus during<br />

2006-2007 . Parents were invited to include their PFAPA diagnosed<br />

children in the study and to sign inform consent forms as customary .<br />

Clinical information was complemented during physicians-parents encounter<br />

and a blood sample was drawn for molecular testing . PCR and<br />

RFLPs for the predominant mutations in MEFV, TNF1A and CARD15/<br />

NOD2 genes were performed .<br />

The cohort consisted <strong>of</strong> 57 children with PFAPA [33 (58%) boys; 24<br />

(42%) girls] . The mean age at diagnosis was 30 .64±16 .4 months,<br />

boys were diagnosed earlier than girls (26 .18±13 .83 and 36 .41±18 .32<br />

months, respectively, p=0 .05) . Predominant mutations in the MEFV<br />

genes were found in 16 (28 .1%) children, mutations in TNF1A were<br />

found in 3 (5 .2%) children and mutations in CARD15 also in 3 (5 .2%)<br />

children . The clinical symptoms (e .g . pharangytis, aphthous stomatitis,<br />

abdominal pain and cervical adenitis) were equally manifested<br />

between carriers and non-carriers .<br />

In Israeli children diagnosed with PFAPA a higher frequency <strong>of</strong> mutations<br />

in MEFV gene were found compared to that observed in the<br />

general population .<br />

P01.345<br />

Analysis <strong>of</strong> the cAG repeat and A467t and W748s POLG<br />

mutations in iranian patients With multiple sclerosis<br />

H. Soltanzadeh 1 , M. Ataei 2 , M. Shaf 2 , M. Houshmand 2 , M. Nabavi 3 , K. Parivar 4 ,<br />

M. Ariany 5 , M. H. Sanati 2 ;<br />

1 Young researchers club. Science and Research <strong>of</strong> Islamic Azad University.<br />

National Institute for Genetic Engineering and Biotechnology, Tehran, Islamic<br />

Republic <strong>of</strong> Iran, 2 National Institute for Genetic Engineering and Biotechnology,<br />

Tehran, Islamic Republic <strong>of</strong> Iran, 3 Shahed university, Tehran, Islamic Republic<br />

<strong>of</strong> Iran, 4 Science and Research Islamic Azad University, Tehran, Islamic Republic<br />

<strong>of</strong> Iran, 5 Special Medical center, Tehran, Islamic Republic <strong>of</strong> Iran.<br />

Multiple sclerosis (MS) is an autoimmune multifactorial disease that<br />

usually develops in susceptible young adults . A possible involvement<br />

<strong>of</strong> mitochondria in MS has been postulated because <strong>of</strong> a higher rate<br />

transmission <strong>of</strong> the disease from mother to child than from father to<br />

child . Also association between Leber’s Hereditary Optic Neuropathy<br />

a mitochondrial disease and MS is another evidence . Fatigue is a common<br />

problem <strong>of</strong> the MS patients which is relted to the energy production<br />

difficulty by the mitochondria. To investigate further the relationship<br />

between MS and mitochondria we analysed the gene encoding<br />

for polymerase G (POLG) . Among the nearly 50 disease mutations in<br />

the gene for the catalytic subunit <strong>of</strong> POLG, The A467T mutant enzyme<br />

possesses only 4% <strong>of</strong> wild-type DNA polymerase activity .<br />

Polymerase gene (pol G) is a two-subunit complex consisting <strong>of</strong> a<br />

140-kDa catalytic and a 55-kDa accessory subunit (p55the Nterminalcatalytic<br />

subunit contains a trinucleotide CAG repeat encoding a polyglutamine<br />

tract near the amino-terminus <strong>of</strong> the protein . Expansions<br />

<strong>of</strong> similar polyglutamine-encoding CAG microsatellite repeats in other<br />

genes are known to cause neurodegenerative disorders .<br />

Total genomic DNA was extracted from 60 idiopathic Ms Patients and<br />

40 controls . Primers were designed to amplify the 4 hot exones and<br />

CAG repeat length <strong>of</strong> the gene following by sequencing . The distribution<br />

<strong>of</strong> the POLG CAG repeat length in the control samples matched<br />

the distribution reported for control samples by others . The analysis<br />

<strong>of</strong> our sample shows no difference between the CAG repeat length<br />

distribution <strong>of</strong> control and ms disease samples analysis <strong>of</strong> exon 7, 8, 9,<br />

and13 <strong>of</strong> POLG gene from 60 DNA samples <strong>of</strong> MS patients showed no<br />

mutation . However this does not exclude the association <strong>of</strong> the gene<br />

in MS but it needs more investigation . Also it is necessary to test the<br />

other exones <strong>of</strong> the gene .<br />

P01.346<br />

TCF deletions in Pitt-Hopkins syndrome<br />

I. Giurgea1,2,3 , C. Missirian4 , S. Whalen1,2,3 , T. Fredriksen1,2,3 , T. Gaillon1,2,3 , J.<br />

Rankin5 , M. Mathieu-Dramard6 , G. Morin6 , D. Martin-Coignard7 , B. Chabrol8 ,<br />

J. Arfi9 , F. Giuliano10 , J. Lambert10 , L. Villard11 , N. Philip12,9 , M. Goossens1,2,3 , A.<br />

Moncla12,9 ;<br />

1INSERM U841, IMRB, département de génétique, Equipe 11, Créteil, France,<br />

2 3 Université Paris 12, Faculté de Médecine, IFR10, Créteil, France, AP-HP,<br />

Groupe Hospitalier Henri Mondor-Albert Chenevier, Service de biochimie et<br />

génétique, Créteil, France, 42Département de Génétique Médicale, Hôpital<br />

des enfants de la Timone, Marseille, France, 5Department <strong>of</strong> Clinical <strong>Genetics</strong>,<br />

Royal Devon and Exeter NHS Foundation Trust (Heavitree), Exeter, United Kingdom,<br />

6Département de Génétique Médicale, CHU d’Amiens - Nord, Amiens,<br />

France, 7Département de Génétique Médicale, CH du Mans, Le Mans, France,<br />

8Service de Neuropédiatrie, Hôpital des enfants de la Timone, Marseille, France,<br />

9Unité INSERM U491 « Génétique Médicale & Développement », Faculté<br />

de Médecine La Timone, Marseille, France, 10Service de Génétique, Hôpital<br />

L’Archet 2, Nice, France, 11Faculté de Médecine La Timone, Marseille, France,<br />

12Département de Génétique Médicale, Hôpital des enfants de la Timone, Marseille,<br />

France.<br />

Background: Pitt-Hopkins syndrome (PHS) is a syndromic mental retardation<br />

disorder marked by hyperventilation episodes and characteristic<br />

dysmorphism (large beaked nose, wide mouth, fleshy lips, and<br />

clubbed fingertips). PHS has been shown to be caused by de novo<br />

heterozygous mutations <strong>of</strong> the TCF4 gene, located in 18q21 . To expand<br />

the phenotypic spectrum <strong>of</strong> mutations and deletions <strong>of</strong> the TCF4<br />

gene, we studied 30 hitherto unexplored patients whose phenotype<br />

overlapped with PHS .<br />

Methods: The TCF4 gene was analysed by QMF-PCR, followed by<br />

sequencing . Large deletions were characterised by CGH array . All patients<br />

were karyotyped .<br />

Results: In three patients, 18q21 .1-q22 .2 deletions were revealed by

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!